Onesource Specialty Pharma Limited — Credit Ratings, 18-08-2026: Credit Rating

India Ratings & Research (Ind-Ra) upgraded OneSource Specialty Pharma's long-term bank loan facilities to 'IND A'/Positive from 'IND A-'. The short-term rating was affirmed at 'IND A1'. The upgrade reflects a stronger business profile from successful drug-device commercialization and rising GLP-1 supplies, shifting to a commercial supply-led model. Ind-Ra also assigned 'IND A/Positive/IND A1' to new bank facilities totaling ₹428.71 Cr.